Advisory Council for the Elimination of Tuberculosis (ACET), 8699-8700 [E8-2796]

Download as PDF Federal Register / Vol. 73, No. 31 / Thursday, February 14, 2008 / Notices Board of Governors of the Federal Reserve System, February 11, 2008. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E8–2766 Filed 2–13–07; 8:45 am] BILLING CODE 6210–01–S GOVERNMENT ACCOUNTABILITY OFFICE Advisory Council on Government Auditing Standards; Notice of Meeting The Advisory Council on Government Auditing Standards will meet Monday, February 25, 2008, from 8:30 a.m. to 4:30 p.m., in room 7C13 of the Government Accountability Office building, 441 G Street, NW., Washington, DC. The Advisory Council on Government Auditing Standards will hold a meeting to discuss issues associated with the independence standard and other issues identified by the Council. The meeting is open to the public. Members of the public will be provided an opportunity to address the Council with a brief (five minute) presentation in the afternoon. Any interested person who plans to attend the meeting as an observer must contact Jennifer Allison, Council Administrator, 202–512–3423. A form of picture identification must be presented to the GAO Security Desk on the day of the meeting to obtain access to the GAO building. For further information, please contact Ms. Allison. Please check the Government Auditing Standards Web page (https://www.gao.gov/govaud/ ybk01.htm) one week prior to the meeting for a final agenda. [Pub. L. 67–13, 42 Stat. 20 (June 10, 1921)] Dated: February 6, 2008. Paula M. Rascona, Director, Financial Management and Assurance. [FR Doc. 08–641 Filed 2–13–08; 8:45 am] BILLING CODE 1610–02–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Meeting of the President’s Council on Bioethics Department of Health and Human Services, Office of Public Health and Science, The President’s Council on Bioethics. ACTION: Notice. rwilkins on PROD1PC63 with NOTICES AGENCY: SUMMARY: The President’s Council on Bioethics (Edmund D. Pellegrino, MD, Chairman) will hold its thirty-second meeting, at which it will discuss and VerDate Aug<31>2005 16:49 Feb 13, 2008 Jkt 214001 hear presentations on (1) newborn screening and (2) the problems of cost, access, and quality in American health care. The Council will also unveil its most recent publication, Human Dignity and Bioethics: Essays Commissioned by the President’s Council on Bioethics. Subjects discussed at past Council meetings (although not on the agenda for the March 2008 meeting) include: therapeutic and reproductive cloning, assisted reproduction, reproductive genetics, neuroscience, aging retardation, organ transplantation, personalized medicine, and lifespanextension. Publications issued by the Council to date include: Human Cloning and Human Dignity: An Ethical Inquiry (July 2002); Beyond Therapy: Biotechnology and the Pursuit of Happiness (October 2003); Being Human: Readings from the President’s Council on Bioethics (December 2003); Monitoring Stem Cell Research (January 2004), Reproduction and Responsibility: The Regulation of New Biotechnologies (March 2004), Alternative Sources of Human Pluripotent Stem Cells: A White Paper (May 2005), Taking Care: Ethical Caregiving in Our Aging Society (September 2005), and Human Dignity and Bioethics: Essays Commissioned by the President’s Council on Bioethics (March 2008). Reports on (a) controversies in the determination of death, and (b) organ procurement, transplantation, and allocation are forthcoming. DATES: The meeting will take place Thursday, March 6, 2008, from 9 a.m. to 5 p.m., ET; and Friday, March 7, 2008, from 8:30 a.m. to 12 noon, ET. ADDRESSES: Hotel Palomar Arlington, 1121 North 19th Street, Arlington, VA 22209. Phone 703–351–9170. FOR FURTHER INFORMATION CONTACT: Ms. Diane M. Gianelli, Director of Communications, The President’s Council on Bioethics, 1425 New York Avenue, NW., Suite C100, Washington, DC 20005. Telephone: 202/296–4669. Email: info@bioethics.gov. Web site: https://www.bioethics.gov. SUPPLEMENTARY INFORMATION: The meeting agenda will be posted at https://www.bioethics.gov. The Council encourages public input, either in person or in writing. At this meeting, interested members of the public may address the Council, beginning at 11:45 am, on Friday, March 7. Comments are limited to no more than five minutes per speaker or organization. As a courtesy, please inform Ms. Diane M. Gianelli, Director of Communications, in advance of your intention to make a public statement, and give your name and affiliation. To submit a written PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 8699 statement, mail or e-mail it to Ms. Gianelli at one of her contact addresses given above. Dated: February 1, 2008. F. Daniel Davis, Executive Director, The President’s Council on Bioethics. [FR Doc. E8–2779 Filed 2–13–08; 8:45 am] BILLING CODE 4154–06–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis (ACET) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–5 p.m., March 26, 2008; 8:30 a.m.–2 p.m., March 27, 2008. Place: Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333, Telephone: (404) 639–8317. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters To Be Discussed: Agenda items include issues pertaining to Lessons Learned: Potential for Transmission of Tuberculosis during Air Travel; Tuberculosis as a Cause of Death; and Update on Nucleic Acid Amplification Testing and Second Line Drug Susceptibility Guidelines and other related tuberculosis issues. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Margie Scott-Cseh, Coordinating Center for Infectious Diseases, Strategic Business Unit, 1600 Clifton Road, NE., M/S E–07, Atlanta, Georgia 30333, Telephone: (404) 639–8317. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\14FEN1.SGM 14FEN1 8700 Federal Register / Vol. 73, No. 31 / Thursday, February 14, 2008 / Notices Dated: February 6, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E8–2796 Filed 2–13–08; 8:45 am] Dated: February 6, 2008. Elaine L. Baker, Director, Management Analysis and Service Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E8–2795 Filed 2–13–08; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Breast and Cervical Cancer Early Detection and Control Advisory Committee (BCCEDCAC) Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Monitoring and Evaluation of Malaria Activities in the Greater Mekong Sub-Region, Request for Applications (RFA) CK08–003 rwilkins on PROD1PC63 with NOTICES In accordance with section 10(a)(2)of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–5p.m., March 4, 2008. 8:30 a.m.–1p.m., March 5, 2008. Place: Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Tom Harkin Global Community Center, Building 19, Atlanta, Georgia 30333, Telephone: (404) 639–1717. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with advising the Secretary, Department of Health and Human Services, and the Director, CDC, regarding the early detection and control of breast and cervical cancer. The committee makes recommendations regarding national program goals and objectives; implementation strategies; and program priorities including surveillance, epidemiologic investigations, education and training, information dissemination, professional interactions and collaborations, and policy. Matters To Be Discussed: The agenda will include a review and discussion of the National Breast and Cervical Cancer Early Detection Program components; and related policies and emerging issues. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Debra Younginer, Executive Secretary, BCCEDCAC, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, Mailstop K–57, Chamblee, Georgia 30316, Telephone: (770) 488–1074. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate Aug<31>2005 16:49 Feb 13, 2008 Jkt 214001 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12 p.m.–2 p.m., March 13, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Monitoring and Evaluation of Malaria Activities in the Greater Mekong Sub-Region, RFA CK08–003.’’ Contact Person For More Information: Christine Morrison, PhD, Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 7, 2008. Elaine L. Baker Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–2793 Filed 2–13–08; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Natural History and Prevention of Viral Hepatitis Among Alaska Natives, Request for Applications (RFA) PS08–004 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12 p.m.–4 p.m., March 24, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Natural History and Prevention of Viral Hepatitis Among Alaska Natives, RFA PS08–004.’’ Contact Person for More Information: Shree Marshall Williams, PhD, M.Sc., Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639–4896. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 8, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–2799 Filed 2–13–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Office of the Director, Office of Strategy and Innovation, Office of Minority Health and Health Disparities In accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of September 23, 2004, Consultation and Coordination with Indian Tribal Governments, the CDC announces the following meeting: Name: Tribal Consultation Advisory Committee (TCAC) Meeting, An E:\FR\FM\14FEN1.SGM 14FEN1

Agencies

[Federal Register Volume 73, Number 31 (Thursday, February 14, 2008)]
[Notices]
[Pages 8699-8700]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-2796]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis (ACET)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

    Times and Dates: 8:30 a.m.-5 p.m., March 26, 2008; 8:30 a.m.-2 
p.m., March 27, 2008.
    Place: Corporate Square, Building 8, 1st Floor Conference Room, 
Atlanta, Georgia 30333, Telephone: (404) 639-8317.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This council advises and makes recommendations to the 
Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis. Specifically, the Council makes recommendations 
regarding policies, strategies, objectives, and priorities; 
addresses the development and application of new technologies; and 
reviews the extent to which progress has been made toward 
eliminating tuberculosis.
    Matters To Be Discussed: Agenda items include issues pertaining 
to Lessons Learned: Potential for Transmission of Tuberculosis 
during Air Travel; Tuberculosis as a Cause of Death; and Update on 
Nucleic Acid Amplification Testing and Second Line Drug 
Susceptibility Guidelines and other related tuberculosis issues. 
Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Margie Scott-Cseh, 
Coordinating Center for Infectious Diseases, Strategic Business 
Unit, 1600 Clifton Road, NE., M/S E-07, Atlanta, Georgia 30333, 
Telephone: (404) 639-8317.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.


[[Page 8700]]


    Dated: February 6, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
 [FR Doc. E8-2796 Filed 2-13-08; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.